Amgen granted Mantecorp rights to market Vectibix panitumumab, Mimpara cinacalcet and romiplostim in Brazil

Amgen Inc.

U.S. / Large-Cap Biopharma (>=$50 billion)

$50,259.2m on 04/08/2011 [market cap]

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Mantecorp Industria Quimica e Farmaceutica S.A.

Brazil / Private Biopharma

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Hypermarcas S.A.

Brazil / Other

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Terminated

Sample

01/01/2009

announced

01/01/2009

Terminated